What are Cumberland Pharmaceuticals's profit margins?

Cumberland Pharmaceuticals (CPIX) runs a 82.9% gross margin and a -17.2% operating margin, with a -17.6% net margin.

Where do Cumberland Pharmaceuticals's ratios come from?

Every ratio is computed from Cumberland Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Cumberland Pharmaceuticals CPIX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	82.9%-1.4pp	85%+2.4pp	84.5%+1.2pp	84%+1.4pp	84.3%+0.8pp
Operating margin	-17.2%-9.2pp	-6.3%+10.7pp	-7.9%+21.4pp	-7.1%+21.8pp	-8%+17.5pp
Net margin	-17.6%-9.6pp	-6.4%+10.7pp	-8.1%+21.5pp	-7%+20.5pp	-8%+13.7pp
EBITDA margin	-6.7%-10.4pp	3%+7.1pp	3.2%+19.9pp	4%+20.3pp	3.7%+16.7pp
Returns
Return on equity	-29.4%-17.7pp	-11.9%+12.8pp	-13.1%+22.7pp	-10.8%+21.9pp	-11.7%+14.7pp
Return on assets	-10.5%-6.2pp	-3.7%+4.5pp	-4.7%+8.6pp	-4%+8.4pp	-4.3%+5.5pp
Return on invested capital	-42.2%-22.5pp	-16.6%+23.3pp	-22.8%+37.2pp	-19%+36.8pp	-19.7%+30.8pp
Efficiency
Asset turnover	0.6×+0.1×	0.6×+0.1×	0.6×+0.1×	0.6×+0.1×	0.5×+0.1×
Inventory turnover	0.7×+0.2×	0.7×+0.1×	0.6×0.0×	0.6×-0.1×	0.6×-0.1×
Liquidity
Current ratio	1×-0.3×	1×-0.1×	1.2×+0.1×	1.3×-0.1×	1.2×-0.1×
Quick ratio	0.7×-0.2×	0.8×0.0×	0.9×+0.1×	0.9×-0.1×	0.9×0.0×
Cash ratio	0.3×-0.3×	0.3×-0.3×	0.6×+0.1×	0.7×0.0×	0.6×-0.1×
Leverage
Debt-to-equity	0.2×0.0×	0.2×-0.3×	0.2×0.0×	0.2×0.0×	0.2×0.0×
Debt-to-assets	0.1×0.0×	0.1×-0.1×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Interest coverage	-17.3×-12.2×	-5.6×+5.0×	-5.4×+13.8×	-4.7×+15.8×	-5×+11.5×
Per Share
Book value per share	$1.45-23.0%	$1.67+3.0%	$1.75-1.0%	$1.87+0.2%	$1.88-3.7%
Valuation
Market capitalization	$97.09M+142%	$59.53M+78.9%	$46.68M+158%	$49.37M+129%	$59.09M+149%
Enterprise value	$90.91M+212%	$53.02M+106%	$36.48M+508%	$38.38M+295%	$49.18M+360%
Price / sales	2.3×+1.4×	1.3×+0.5×	1.1×+0.6×	1.2×+0.6×	1.4×+0.8×
Price / book	4.5×+3.1×	2.4×+0.9×	1.8×+1.1×	1.8×+0.9×	2.1×+1.2×
EV / sales	2.2×+1.5×	1.2×+0.5×	0.9×+0.7×	0.9×+0.7×	1.2×+0.9×
Earnings yield	-7.6%-0.3pp	-4.8%+14.7pp	-7.1%+53.0pp	-5.9%+42.2pp	-5.5%+30.0pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Cumberland Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Cumberland Pharmaceuticals's profit margins?: Cumberland Pharmaceuticals (CPIX) runs a 82.9% gross margin and a -17.2% operating margin, with a -17.6% net margin.
Where do Cumberland Pharmaceuticals's ratios come from?: Every ratio is computed from Cumberland Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.